Mark Pollack to Depressive Disorder
This is a "connection" page, showing publications Mark Pollack has written about Depressive Disorder.
Connection Strength
2.599
-
Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012 Jun; 80(3):404-15.
Score: 0.390
-
Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients. Int Clin Psychopharmacol. 2005 Jan; 20(1):9-11.
Score: 0.235
-
Comorbid anxiety and depression. J Clin Psychiatry. 2005; 66 Suppl 8:22-9.
Score: 0.235
-
Collaborative Care for Depression of Adults and Adolescents: Measuring the Effectiveness of Screening and Treatment Uptake. Psychiatr Serv. 2019 07 01; 70(7):604-607.
Score: 0.158
-
Evaluating patterns and predictors of symptom change during a three-week intensive outpatient treatment for veterans with PTSD. BMC Psychiatry. 2018 07 27; 18(1):242.
Score: 0.150
-
Examining the Relationship Between Parent and Child Psychopathology in Treatment-Seeking Veterans. Child Psychiatry Hum Dev. 2018 04; 49(2):209-216.
Score: 0.147
-
Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo. J Affect Disord. 1994 Apr; 30(4):273-81.
Score: 0.111
-
Treatment of fluoxetine-induced sexual dysfunction with bupropion: a case report. Ann Clin Psychiatry. 1994 Mar; 6(1):13-5.
Score: 0.111
-
Adjunctive yohimbine for treatment in refractory depression. Biol Psychiatry. 1993 Feb 01; 33(3):220-1.
Score: 0.103
-
Anhedonic ejaculation with desipramine. Int J Psychiatry Med. 1988; 18(1):85-8.
Score: 0.072
-
Examination of the decline in symptoms of anxiety and depression in generalized anxiety disorder: impact of anxiety sensitivity on response to pharmacotherapy. Depress Anxiety. 2008; 25(2):167-71.
Score: 0.072
-
Complicated grief: a case series using escitalopram. Am J Psychiatry. 2007 Nov; 164(11):1760-1.
Score: 0.071
-
Verapamil in the treatment of recurrent unipolar depression. Biol Psychiatry. 1987 Jun; 22(6):779-82.
Score: 0.069
-
Propranolol and depression revisited: three cases and a review. J Nerv Ment Dis. 1985 Feb; 173(2):118-9.
Score: 0.059
-
Somatic panic-attack equivalents in a community sample of Rwandan widows who survived the 1994 genocide. Psychiatry Res. 2003 Jan 25; 117(1):1-9.
Score: 0.051
-
History of childhood abuse in panic disorder, social phobia, and generalized anxiety disorder. J Nerv Ment Dis. 2002 Jul; 190(7):453-6.
Score: 0.049
-
Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder. J Clin Psychiatry. 2001; 62 Suppl 12:24-9.
Score: 0.044
-
Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder. Am J Psychiatry. 2000 Jun; 157(6):968-74.
Score: 0.043
-
Quality of life in patients with panic disorder. J Nerv Ment Dis. 1999 Jul; 187(7):429-34.
Score: 0.040
-
Additional findings on the association between anxiety sensitivity and hypochondriacal concerns: examination of patients with major depression. J Anxiety Disord. 1998 May-Jun; 12(3):225-32.
Score: 0.037
-
Prevalence and correlates of anger attacks: a two site study. J Affect Disord. 1996 Jun 20; 39(1):31-8.
Score: 0.032
-
Predicting prospective episodes of depression in patients with panic disorder: a longitudinal study. J Consult Clin Psychol. 1994 Apr; 62(2):359-65.
Score: 0.028
-
Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo. J Affect Disord. 1993 May; 28(1):27-38.
Score: 0.026
-
Personality disorders in patients with panic disorder: association with childhood anxiety disorders, early trauma, comorbidity, and chronicity. Compr Psychiatry. 1992 Mar-Apr; 33(2):78-83.
Score: 0.024
-
Major depression in panic disorder patients with comorbid social phobia. J Affect Disord. 1991 Jul; 22(3):171-7.
Score: 0.023
-
Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study. J Clin Psychiatry. 1990 Dec; 51 Suppl A:12-6.
Score: 0.022
-
The antidepressant potential of oral S-adenosyl-l-methionine. Acta Psychiatr Scand. 1990 May; 81(5):432-6.
Score: 0.021
-
Neuroendocrine effects of S-adenosyl-L-methionine, a novel putative antidepressant. J Psychiatr Res. 1990; 24(2):177-84.
Score: 0.021
-
Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry. 1989 Dec; 50(12):447-9.
Score: 0.021
-
Acute distress after switch from Norpramin to generic desipramine. Am J Psychiatry. 1989 Jan; 146(1):122.
Score: 0.019
-
An open-label pilot study of oral S-adenosylmethionine in major depression. An interim report. Ala J Med Sci. 1988 Jul; 25(3):301-6.
Score: 0.019
-
An open-label pilot study of oral S-adenosyl-L-methionine in major depression: interim results. Psychopharmacol Bull. 1988; 24(1):189-94.
Score: 0.018
-
Management of antidepressant-induced side effects: a practical guide for the clinician. J Clin Psychiatry. 1987 Jan; 48(1):3-8.
Score: 0.017
-
Enhancement of ECT benefit by yohimbine. J Clin Psychiatry. 1986 Oct; 47(10):508-10.
Score: 0.017
-
EFFECTS OF CHLORPROMAZINE AND IMIPRAMINE ON SYSTOLIC BLOOD PRESSURE IN PSYCHIATRIC PATIENTS: RELATIONSHIPS TO AGE, DIAGNOSIS AND INITIAL BLOOD PRESSURE. J Psychiatr Res. 1964 Jan; 2:51-60.
Score: 0.014
-
Childhood history of anxiety disorders among adults with social phobia: rates, correlates, and comparisons with patients with panic disorder. Depress Anxiety. 2001; 14(4):209-13.
Score: 0.011
-
Clinical issues in the long-term treatment of panic disorder. J Clin Psychiatry. 1996; 57 Suppl 10:44-8; discussion 49-50.
Score: 0.008
-
Alcohol dependence in panic disorder patients. J Psychiatr Res. 1992 Jan; 26(1):29-38.
Score: 0.006
-
Fluoxetine-induced sexual dysfunction. J Clin Psychiatry. 1990 Jan; 51(1):25-7.
Score: 0.005